National Jewish Hospital

Denver, Colorado 80206-2761

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Cystic Fibrosis, LAM, Lymphangioleiomyomatosis, Non-cystic Fibrosis Bronchiectasis, Primary Immunodeficiency

Studies at this site

• Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough — Completed
• Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial — Running, not enrolling
• Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% — Completed
• Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis — Completed
• The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial — Completed
• NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients — Completed
• Trial of Asthma Patient Education (TAPE) — Completed